- Home
- SBFM vs XXII Comparison
SBFM vs XXII Comparison
Compare SBFM & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- XXII
- Stock Information
- Founded
- SBFM 2006
- XXII 1998
- Country
- SBFM United States
- XXII United States
- Employees
- SBFM N/A
- XXII N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- XXII Medicinal Chemicals and Botanical Products
- Sector
- SBFM Health Care
- XXII Health Care
- Exchange
- SBFM Nasdaq
- XXII Nasdaq
- Market Cap
- SBFM 6.7M
- XXII 6.2M
- IPO Year
- SBFM N/A
- XXII N/A
- Fundamental
- Price
- SBFM $1.75
- XXII $1.54
- Analyst Decision
- SBFM Strong Buy
- XXII
- Analyst Count
- SBFM 1
- XXII 0
- Target Price
- SBFM $7.00
- XXII N/A
- AVG Volume (30 Days)
- SBFM 71.9K
- XXII 3.6M
- Earning Date
- SBFM 11-04-2025
- XXII 11-11-2025
- Dividend Yield
- SBFM N/A
- XXII N/A
- EPS Growth
- SBFM N/A
- XXII N/A
- EPS
- SBFM N/A
- XXII N/A
- Revenue
- SBFM $36,341,741.00
- XXII $21,362,000.00
- Revenue This Year
- SBFM $32.20
- XXII N/A
- Revenue Next Year
- SBFM $32.74
- XXII $126.57
- P/E Ratio
- SBFM N/A
- XXII N/A
- Revenue Growth
- SBFM 19.22
- XXII N/A
- 52 Week Low
- SBFM $1.17
- XXII $1.46
- 52 Week High
- SBFM $3.90
- XXII $491.83
- Technical
- Relative Strength Index (RSI)
- SBFM 66.08
- XXII 41.83
- Support Level
- SBFM $1.50
- XXII $1.46
- Resistance Level
- SBFM $1.74
- XXII $1.59
- Average True Range (ATR)
- SBFM 0.09
- XXII 0.14
- MACD
- SBFM 0.01
- XXII 0.02
- Stochastic Oscillator
- SBFM 96.84
- XXII 11.51
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.